Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasms, Male × Testosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Breast Neoplasms, Male 1

Interventions

Magnetic Resonance Spectroscopy 4 Immunoenzyme Techniques 3 Cyclophosphamide 3 saponin QA-21V1 2 exemestane 2 Vorinostat 2 Therapeutics 2 Letrozole 2 Immunologic Techniques 2 Gene Expression Profiling 2 Early Intervention, Educational 2 Doxorubicin 2 Docetaxel 2 Chemotherapy, Adjuvant 2 Biopsy 2 Bevacizumab 2 Anastrozole 2 Acupuncture Therapy 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 pegfilgrastim 1 iso-sulfan blue 1 alovudine 1 Zoledronic Acid 1 Trastuzumab 1 Thoracoscopy 1 Testosterone 1 Technetium Tc 99m Sulfur Colloid 1 Taxes 1 Surgical Procedures, Operative 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05156606 2024-08-09

T&T

University Medical Center Groningen

Phase NA Terminated

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡